Neuland Laboratories Ltd (NEULANDLAB) — Announcement | 16 September 2026

16 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Management to participate in Goldman Sachs Healthcare CDMO Day

💡 Investor Takeaway

This meeting offers investors direct access to management for discussing the company's healthcare CDMO strategy.

Neuland Laboratories announced its management will attend the Goldman Sachs Global Healthcare CDMO Day in Singapore from September 23-25, 2026, as part of scheduled investor meetings. The filing confirms participation but notes the schedule may change due to participant or company exigencies, with no financial details or forward-looking statements provided.

📄 View Original Announcement (PDF)

📊 Stock Analysis — NEULANDLAB ✨ Ask AI About This

About Neuland Laboratories Ltd (NEULANDLAB)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹27,498.49 CrP/E: 55.2ROE: 26.6%ROCE: 33.6%Div Yield: 0.16%

View full NEULANDLAB stock details →

📡 Get AI alerts when NEULANDLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NEULANDLAB — Free

💡 Ask AI about this filing

"What specific CDMO capabilities will Neuland showcase?""How does this event align with their revenue growth targets?""What is the expected follow-up engagement timeline?"

Ask AI Free →

📊 More NEULANDLAB filings

Announcement — 25 September 2026Neuland Laboratories has closed its insider trading window effective October 1, 2026, until 48 hours...
🔴 Announcement — 15 September 2026Neuland Laboratories announced that its first commercial peptide manufacturing module is now operati...
🔴 Announcement — 9 September 2026Neuland Laboratories announced its management will attend three upcoming investor meetings in Septem...
🟡 Board Meeting — 7 September 2026Neuland Laboratories announced on September 7, 2026, that its board approved ₹126 crores capital exp...
🔴 Announcement — 25 August 2026Neuland Laboratories Limited announced that CRISIL has reaffirmed its long-term rating at CRISIL A+ ...

See all NEULANDLAB filings →

🔥 Also filed on 16 September 2026

BLBLIMITEDBLB LtdInsider Trading RUBFILARubfila International LtdCorporate Action AXISBANKAxis Bank LtdCorporate Action BPCLBharat Petroleum Corporation LtdAnnouncement KANOHARKanohar Electricals LtdInsider Trading TBZTribhovandas Bhimji Zaveri LtdOffer Document

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NEULANDLAB files new disclosures

Track NEULANDLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.